Format
Sort by
Items per page

Send to

Choose Destination

Best matches for zika[tiab] AND guillain-barre:

Guillain-Barré syndrome and Zika virus infection. Wiwanitkit V et al. Arq Neuropsiquiatr. (2016)

Zika virus and Guillain-Barré syndrome. Ellul MA et al. J R Coll Physicians Edinb. (2016)

Association between Guillain-Barré syndrome and Zika virus infection. Bautista LE et al. Lancet. (2016)

Search results

Items: 1 to 20 of 530

1.

Efficiencies and kinetics of infection in different cell types/lines by African and Asian strains of Zika virus (ZIKV).

da Silva SR, Cheng F, Huang IC, Jung JU, Gao SJ.

J Med Virol. 2018 Sep 7. doi: 10.1002/jmv.25306. [Epub ahead of print]

PMID:
30192399
2.

[The most frequent causative agents of Guillain-Barre syndrome in a Mexican general hospital].

Del Carpio-Orantes L, Pola-Ramirez MR, Garcia-Mendez S, Mata-Miranda MP, Perfecto-Arroyo MA, Solis-Sanchez I, Trujillo-Ortega BM, Gonzalez-Flores EE.

Rev Neurol. 2018 Sep 16;67(6):203-209. Spanish.

3.

[Cases of Zika virus infection in Turkey: newly married couple returning from Cuba].

Sezen Aİ, Yıldırım M, Kültür MN, Pehlivanoğlu F, Menemenlioğlu D.

Mikrobiyol Bul. 2018 Jul;52(3):308-315. doi: 10.5578/mb.66991. Turkish.

PMID:
30156517
4.

Long-term clinical outcomes of Zika-associated Guillain-Barré syndrome.

Chang AY, Lynch R, Martins K, Encinales L, Cadena Bonfanti AÁ, Pacheco N, Reid SP, Lara Sarabia OE, González Torres HJ, Mejia Castillo S, Barrios Taborda O, Alarcon Gomez M, Guerra Duran B, Martinez Giraldo V, Benitez Ospino A, Porras A, Mendoza AR, Mantus G, Li G, Peng J, Kamalapathy P, Avendaño Echavez LG, Dowd KA, Rengifo-Pardo M, Barraza PP, Jiménez Hernàndez D, González Coba A, De La Hoz Mendoza K, Bethony JM, Simon GL.

Emerg Microbes Infect. 2018 Aug 22;7(1):148. doi: 10.1038/s41426-018-0151-9. No abstract available.

5.

Risk of Zika virus transmission by blood donations in Brazil.

Magnus MM, Espósito DLA, Costa VAD, Melo PS, Costa-Lima C, Fonseca BALD, Addas-Carvalho M.

Hematol Transfus Cell Ther. 2018 Jul-Sep;40(3):250-254. doi: 10.1016/j.htct.2018.01.011. Epub 2018 Apr 23.

6.

Augmented Zika and dengue neutralizing antibodies are associated with Guillain-Barré syndrome.

Lynch RM, Mantus G, Encinales L, Pacheco N, Li G, Porras A, Mendoza AR, Peng J, Rengifo-Pardo M, Cruz MM, Harris E, Bethony JM, Simon GL, Chang AY.

J Infect Dis. 2018 Aug 3. doi: 10.1093/infdis/jiy466. [Epub ahead of print]

PMID:
30113672
7.

Untold stories of the Zika virus epidemic in Brazil.

Avelino-Silva VI, Kallas EG.

Rev Med Virol. 2018 Aug 3:e2000. doi: 10.1002/rmv.2000. [Epub ahead of print] Review.

PMID:
30074287
8.

Guillain-Barré syndrome associated with Zika virus infection: Analysis of a cohort from the region of northern Veracruz in 2016-2017.

Del Carpio-Orantes L, Peniche Moguel KG, Sánchez Díaz JS, Pola-Ramirez MDR, Mata Miranda MDP, García-Méndez S, Perfecto-Arroyo MA, Solís-Sánchez I, Trujillo-Ortega BM, González-Flores EE.

Neurologia. 2018 Jul 30. pii: S0213-4853(18)30173-7. doi: 10.1016/j.nrl.2018.05.002. [Epub ahead of print] English, Spanish. No abstract available.

9.

Guillain-Barré syndrome associated with zika virus infection in the Americas: A bibliometric study.

Del Carpio Orantes L.

Neurologia. 2018 Jul 30. pii: S0213-4853(18)30171-3. doi: 10.1016/j.nrl.2018.05.001. [Epub ahead of print] English, Spanish. No abstract available.

10.

The 2016 Singapore Zika virus outbreak did not cause a surge in Guillain-Barré syndrome.

Umapathi T, Kam YW, Ohnmar O, Ng BCJ, Ng Y, Premikha M, Leo YS, Ng LFP.

J Peripher Nerv Syst. 2018 Sep;23(3):197-201. doi: 10.1111/jns.12284. Epub 2018 Aug 21.

PMID:
30070025
11.

Prevalence of neurological complications associated with Zika virus in a brazilian metropolis.

Brito KGDS, Dos Santos EB, Lucas LDSM, Orsini M, Fiorelli R, Teixeira S, Ayres C, Correia L, Bastos VH, Trajano E, Cardoso CE, de Freitas MRG, Catharino AMDS.

Neurol Int. 2018 Jul 4;10(2):7638. doi: 10.4081/ni.2018.7638. eCollection 2018 May 24.

12.

Development and validation of a phenotypic high-content imaging assay for assessing the antiviral activity of small-molecule inhibitors targeting the Zika virus.

Bernatchez JA, Yang Z, Coste M, Li J, Beck S, Liu Y, Clark AE, Zhu Z, Luna LA, Sohl CD, Purse BW, Li R, Siqueira-Neto JL.

Antimicrob Agents Chemother. 2018 Jul 30. pii: AAC.00725-18. doi: 10.1128/AAC.00725-18. [Epub ahead of print]

PMID:
30061280
13.

Zika Virus and the Metabolism of Neuronal Cells.

Rothan HA, Fang S, Mahesh M, Byrareddy SN.

Mol Neurobiol. 2018 Jul 24. doi: 10.1007/s12035-018-1263-x. [Epub ahead of print] Review. Erratum in: Mol Neurobiol. 2018 Sep 12;:.

PMID:
30043260
14.

A VSV-based Zika virus vaccine protects mice from lethal challenge.

Emanuel J, Callison J, Dowd KA, Pierson TC, Feldmann H, Marzi A.

Sci Rep. 2018 Jul 23;8(1):11043. doi: 10.1038/s41598-018-29401-x.

15.

Global interactomics uncovers extensive organellar targeting by Zika virus.

Coyaud E, Ranadheera C, Cheng DT, Goncalves J, Dyakov B, Laurent E, St-Germain JR, Pelletier L, Gingras AC, Brumell JH, Kim PK, Safronetz D, Raught B.

Mol Cell Proteomics. 2018 Jul 23. pii: mcp.TIR118.000800. doi: 10.1074/mcp.TIR118.000800. [Epub ahead of print]

16.

Expression of a Zika virus antigen in microalgae: Towards mucosal vaccine development.

Márquez-Escobar VA, Bañuelos-Hernández B, Rosales-Mendoza S.

J Biotechnol. 2018 Sep 20;282:86-91. doi: 10.1016/j.jbiotec.2018.07.025. Epub 2018 Jul 18.

PMID:
30031093
17.

Extract from Aphloia theiformis, an edible indigenous plant from Reunion Island, impairs Zika virus attachment to the host cell surface.

Clain E, Sinigaglia L, Koishi AC, Gorgette O, Gadea G, Viranaicken W, Krejbich-Trotot P, Mavingui P, Desprès P, Nunes Duarte Dos Santos C, Guiraud P, Jouvenet N, El Kalamouni C.

Sci Rep. 2018 Jul 18;8(1):10856. doi: 10.1038/s41598-018-29183-2.

18.

Potential targets for therapeutic intervention and structure based vaccine design against Zika virus.

Qadir A, Riaz M, Saeed M, Shahzad-Ul-Hussan S.

Eur J Med Chem. 2018 Aug 5;156:444-460. doi: 10.1016/j.ejmech.2018.07.014. Epub 2018 Jul 10. Review.

PMID:
30015077
19.

Zika Virus Vaccine: Progress and Challenges.

Shan C, Xie X, Shi PY.

Cell Host Microbe. 2018 Jul 11;24(1):12-17. doi: 10.1016/j.chom.2018.05.021. Epub 2018 Jun 28. Review.

PMID:
30008291
20.

A Reverse Genetics System for Zika Virus Based on a Simple Molecular Cloning Strategy.

Münster M, Płaszczyca A, Cortese M, Neufeldt CJ, Goellner S, Long G, Bartenschlager R.

Viruses. 2018 Jul 12;10(7). pii: E368. doi: 10.3390/v10070368.

Supplemental Content

Loading ...
Support Center